News
SOPH
5.04
-0.40%
-0.02
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
SOPHiA GENETICS will release its financial results for the first quarter of fiscal year 2024 before U.S. Markets open on Tuesday, May 7, 2024. The company will host a conference call to discuss its results. SOPHia is a cloud-native software company and a leader in data-driven medicine.
Barchart · 1d ago
Weekly Report: what happened at SOPH last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at SOPH last week (0408-0412)?
Weekly Report · 04/15 09:22
Weekly Report: what happened at SOPH last week (0401-0405)?
Weekly Report · 04/08 09:24
SOPHiA GENETICS and Strand Life Sciences enter partnership
Healthcare SOPHiA GENETICS and Strand Life Sciences enter partnership. New collaboration will fuel the use of precision medicine globally. The two companies will provide access to advanced genomics technologies, cutting-edge bioinformatics services and innovative diagnostics solutions.
Seeking Alpha · 04/04 06:31
SOPHiA GENETICS And Strand Life Sciences Enter New Strategic Partnership, To Advance The Use Of Precision Medicine
Benzinga · 04/04 06:04
Weekly Report: what happened at SOPH last week (0325-0329)?
Weekly Report · 04/01 09:23
Weekly Report: what happened at SOPH last week (0318-0322)?
Weekly Report · 03/25 09:24
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada
Benzinga · 03/20 14:02
12 Health Care Stocks Moving In Monday's After-Market Session
Ontrak (NASDAQ:OTRK) stock increased by 61.0% to $0.31 during Monday's after-market session. Universe Pharmaceuticals (NASdaq:UPC) shares rose 30.26% in the same session. Augmedix and Sophia Genetics also moved upwards. Losers Acurx Pharmaceuticals, Acutus Medical and Fresh2 Group were among the names in the losers.
Benzinga · 03/18 21:33
Weekly Report: what happened at SOPH last week (0311-0315)?
Weekly Report · 03/18 09:24
SOPHiA Genetics And The French Kidney Cancer Research Network (UroCCR) Publish Results From Multiyear Collaboration On A Study Using A Multimodal Algorithm To Predict Post-operative Outcomes For Those Facing Renal Cell Carcinoma
Benzinga · 03/15 10:08
Weekly Report: what happened at SOPH last week (0304-0308)?
Weekly Report · 03/11 09:23
SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
SOPHiA GENETICS SA (NASDAQ:SOPH) reported revenues of US$62m, in line with expectations. Its shares fell 2.3% in the week after its annual results. Analysts have downgraded their revenue estimates for next year, but the business is expected to grow faster than its industry. The consensus price target for the company remains at US$8.67.
Simply Wall St · 03/09 13:22
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
Chief Financial Officer and Chief Operating Officer, Ross Muken, will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on March 13, 2024. SOPHiA GENETICS is a cloud-native software company and a leader in data-driven medicine.
Barchart · 03/07 11:07
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
United Natural Foods shares dipped 15.2% to $12.61 on Wednesday. The company posted adjusted earnings of 7 cents per share in second-quarter. Rail Vision Ltd. Shares jumped 115.2%. Airship AI Holdings, Inc. Shares climbed 37.8% after gaining 200% on Tuesday.
Benzinga · 03/06 18:54
SOPHiA GENETICS Price Target Raised to $8.00/Share From $7.00 by BTIG
Dow Jones · 03/06 18:15
SOPHiA GENETICS Is Maintained at Buy by BTIG
Dow Jones · 03/06 18:15
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $8
Benzinga · 03/06 18:04
SOPHiA GENETICS Price Target Maintained With a $8.00/Share by RBC Capital
Dow Jones · 03/06 15:31
More
Webull provides a variety of real-time SOPH stock news. You can receive the latest news about Sophia Genetics Sa through multiple platforms. This information may help you make smarter investment decisions.
About SOPH
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.